The Renewed National Cervical Screening Program

The renewed National Cervical Screening Program

The Renewal of the National Cervical Screening Program will be implemented on 1 December 2017.

Until the renewed National Cervical Screening Program is implemented, the cervical cancer screening program will continue. It is important that people aged between 18-69 years continue to have Pap tests every two years and talk to their doctor or healthcare provider if they have any questions.

More accurate. Less often.

From 1 December 2017, cervical screening will change in Australia. The Pap test will be replaced with a new Cervical Screening Test every five years.

Cervical cancer is one of the most preventable cancers. The new Cervical Screening Test is expected to protect up to 30% more women.

The test is a quick and simple procedure to check the health of your cervix. It looks and feels the same as the Pap test, but tests for the human papillomavirus (known as HPV).

Your first Cervical Screening Test is due two years after your last Pap test. After that, you will only need to have the test every five years if your results are normal.

Regular cervical screening is your best protection against cervical cancer. For further information please visit


Bexsero Update

Bexsero Update

BEXSERO® supplies have returned to normal. We have contacted everyone on our waiting list. If you are interesting in commencing the BEXSERO® schedule, please contact our friendly reception team or book an appointment online to discuss this with your Doctor.

What is BEXSERO® and what is it used for?
BEXSERO® is a meningococcal group B vaccine.
BEXSERO® is given to individuals from 2 months of age and older to help protect against disease caused by bacteria called Neisseria meningitidis group B. These bacteria can cause serious, and sometimes life-threatening, infections such as meningitis (inflammation of the covering of the brain and spinal cord) and sepsis (blood poisoning).
The vaccine works by specifically stimulating the body’s natural defense system of the vaccinated person. This results in protection against this disease.

Who should consider having the BEXSERO® immunisation? 
Based on their higher disease risk, 4CMenB is recommended for these groups:

  • Infants and young children, particularly those aged <24 months
  • Adolescents aged 15 to 19 years
  • Children and adults with medical conditions that place them at a high risk of IMD, such as functional or anatomical asplenia or complement component disorders
  • Laboratory personnel who frequently handle Neisseria meningitidis

Worldwide, the main strains that cause meningococcal disease are A, B, C, W and Y.  ** Doctors on Darling also stock the ACWY vaccine 





MERS Coronavirus

MERS Coronavirus (MERS-CoV)

Please ensure you notify reception if you are booking to see  your Doctor when
– Patients have pneumonia or pneumonitis onset within 14days of travelling in countries in or near the Middle East; or
– Where patients have had close contact with ill persons from the Middle East or other places with known MERS-CoV outbreaks

All suspect cases attending Doctors on Darling will be isolated and transmission-based precautions will be followed. It is important to ensure you notify reception priorto attending to discuss this.